BridgeBio Pharma (NASDAQ:BBIO) Reaches New 12-Month High – Should You Buy?
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) shares reached a new 52-week high during trading on Monday . The company traded as high as $72.47 and last traded at $71.7250, with a volume of 94503 shares. The stock had previously closed at $72.01. Analyst Ratings Changes BBIO has been the subject of several research […]
1 Dec 16:40 · The Markets Daily